Drugstore chain retailer,
Rite Aid Corporation
) same-store sales (comps) for the five weeks ended Mar 2, 2013
decreased 3.6%. The decline was primarily due to a fall in
front-end comps as well as in pharmacy comps.
Rite Aid's front-end comps inched down 1.3% while flu-related
over-the-counter product comps remained flat. Despite a 0.3%
increase in prescription counts at comparable stores, Pharmacy
comps for February declined 4.7%. Pharmacy comps for the month
was adversely impacted by about 695 basis points due to the
introduction of new generic drugs. During the period, the decline
in prescription count comprised of a 0.1% decline in flu-related
prescriptions and flu shots.
This Zacks Rank #1 (Strong Buy) company reported total
drugstore sales of $2.457 billion for the month, with
prescription sales accounting for 67.7% of drugstore sales and
third-party prescription sales making up for 96.9% of pharmacy
sales. The company's February sales declined 3.7% from the
year-ago level of $2.551 billion.
For the fiscal 2013 fourth quarter ended on Mar 2, the
company's comps declined 2.0% primarily due to a fall of 3.1% in
Pharmacy comps partially offset by an increase of 0.3%. During
the period, total drugstore sales declined 2.4% to $6.425 billion
compared with $6.585 billion in the fourth quarter of 2012.
Prescription sales comprised 66.5% of total drugstore sales,
while prescription counts increased 3.0% in the fourth quarter.
Additionally, third-party prescription sales accounted for 96.6%
of pharmacy sales.
Fiscal 2013, i.e. for the 52-week period ended on Mar 2, the
company's comps were down by a 0.3%, while total drugstore sales
slipped 0.9% year over year to $25.284 billion. The decrease in
comps was mainly due to a marginal fall of 1.0% in pharmacy comps
partially offset by a 1.4% rise in front-end comps.
Prescription sales comprised 67.6% of total drugstore sales,
while prescription count at comparable stores climbed 3.4% in
fiscal 2013. Additionally, third-party prescription sales
accounted for 96.6% of pharmacy sales.
Other Stocks to Consider
Other drug store stocks that are performing well include
CVS Caremark Corporation
Cardinal Health Inc.
). All these companies currently have a Zacks Rank #2 (Buy).
AMERISOURCEBRGN (ABC): Free Stock Analysis
CARDINAL HEALTH (CAH): Free Stock Analysis
CVS CAREMARK CP (CVS): Free Stock Analysis
RITE AID CORP (RAD): Free Stock Analysis
To read this article on Zacks.com click here.